Allstate reports applications for new credit cards, loans and account setups peak in October during pre-Black Friday shopping, totaling more than $9M in potential losses Key takeaways: — October kicks offidentity theft season, with the highest volume of fraudulent credit and loan applications all year. — Fraud applications account for nearly 70% of all identity […]
The Canadian economy is expected to see slow growth in Q3 and Q4 2025, finds the Canadian Federation of Independent Business's (CFIB) latestMain Street Quarterlyreport. Key highlights of the Q3 2025 edition of the Main Street Quarterly report — CFIB's estimates and forecasts in partnership with AppEco suggest Canadian economy grew by 0.8% in Q3
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=174046&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / October 27, 2025 / If you suffered a loss on your LifeMD, Inc. (NASDAQ:LFMD) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lifemd-inc-lawsuit-submission-form?prid=174047&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
(NasdaqGM:NTLA), CAMBRIDGE, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company has temporarily paused patient dosing and screening for its MAGNITUDE and MAGNITUDE-2 Phase 3 clinical trials of nex-z for patients with transthyretin amyloidosis with
(NASDAQ:BRTX), MELVILLE, N.Y., Oct. 27, 2025 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, today announced a major intellectual property milestone: the Japanese Patent Office has issued a Notice of Allowance for the Company's ThermoStem(R) platform. The newly allowed patent
SEOUL, South Korea, Oct. 27, 2025 (GLOBE NEWSWIRE) — MicrobiotiX Co., Ltd. (CEO Dongeun Yong), a company specializing in the development of novel bacteriophage therapeutics, announced on October 27 that it received Investigational New Drug (IND) approval from the Ministry of Food and Drug Safety (MFDS) on October 21 for MP101, its investigational bacteriophage therapy
(NYSE:BAX), LOS ANGELES, Oct. 27, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Baxter International Inc. (“Baxter” or “the Company”) (NYSE: BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
(Neo:ABXX.NE),(OTC US:ABXXF),(Other OTC:ABXXF), TORONTO, Oct. 27, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company“), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing“), and producer of the SmarterMarkets(TM) Podcast, today announced the
(PinkSheets:BCDS),(Pinksheets:BCDS), ROBESONIA, Pa., Oct. 27, 2025 (GLOBE NEWSWIRE) — Blaqclouds, Inc. (OTC: BCDS), a leading Web3 infrastructure and decentralized finance company, today announced it has entered into a Blockchain & Development Partnership Agreement with Super Studios USA, an emerging powerhouse in film, television, and mixed-use real estate development. Under the terms of the agreement, Super